Variant report
Variant | esv3511179 |
---|---|
Chromosome Location | chr4:120962304-120966302 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr4:120964875-120964999 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr4:120964100-120964250 | NHEK | skin: | n/a | n/a |
3 | IRF1 | chr4:120965027-120965354 | K562 | blood: | n/a | chr4:120965180-120965201 |
4 | IRF1 | chr4:120965013-120965331 | K562 | blood: | n/a | chr4:120965180-120965201 |
5 | IRF1 | chr4:120964821-120965410 | K562 | blood: | n/a | chr4:120965180-120965201 |
6 | SETDB1 | chr4:120964713-120965317 | U2OS | brain: | n/a | n/a |
7 | STAT3 | chr4:120962724-120962883 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:120958158..120959809-chr4:120965003..120967800,2 | K562 | blood: | |
2 | chr4:120965543..120968090-chr4:120982539..120985159,2 | K562 | blood: | |
3 | chr4:120964367..120966016-chr4:120972622..120975603,2 | K562 | blood: | |
4 | chr4:120965102..120968292-chr4:120969292..120973289,4 | K562 | blood: | |
5 | chr4:120956553..120960562-chr4:120961898..120965735,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253825 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559446053 | chr4:120962309-120962310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143808663 | chr4:120962341-120962342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1845344 | chr4:120962385-120962386 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
4 | rs569542868 | chr4:120962396-120962397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182342125 | chr4:120962404-120962405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551962429 | chr4:120962453-120962454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186649201 | chr4:120962466-120962467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562227441 | chr4:120962474-120962475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534295402 | chr4:120962482-120962483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148098514 | chr4:120962483-120962484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs17009347 | chr4:120962561-120962562 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs142342110 | chr4:120962596-120962597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556545892 | chr4:120962614-120962615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575163599 | chr4:120962637-120962638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78086187 | chr4:120962669-120962670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148771644 | chr4:120962693-120962694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190123983 | chr4:120962701-120962702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549544721 | chr4:120962727-120962728 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs146561780 | chr4:120962749-120962750 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs139101791 | chr4:120962807-120962808 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs560024894 | chr4:120962839-120962840 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs529005557 | chr4:120962844-120962845 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs548668148 | chr4:120962852-120962853 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs182398193 | chr4:120962867-120962868 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs80329173 | chr4:120962917-120962918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552148088 | chr4:120962963-120962964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571857438 | chr4:120962987-120962988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187443277 | chr4:120963144-120963145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565509281 | chr4:120963244-120963245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547849789 | chr4:120963251-120963252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143646793 | chr4:120963260-120963261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554300245 | chr4:120963279-120963280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34652096 | chr4:120963280-120963281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200792039 | chr4:120963281-120963282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397879490 | chr4:120963287-120963288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551698671 | chr4:120963321-120963322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568662868 | chr4:120963336-120963337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17009361 | chr4:120963401-120963402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs554289318 | chr4:120963469-120963470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373565930 | chr4:120963534-120963535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556099454 | chr4:120963587-120963588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78565885 | chr4:120963609-120963610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193180751 | chr4:120963624-120963625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557671511 | chr4:120963630-120963631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537189526 | chr4:120963647-120963648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138577157 | chr4:120963721-120963722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138875839 | chr4:120963779-120963780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113241994 | chr4:120963780-120963781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557579253 | chr4:120963802-120963803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185097466 | chr4:120963826-120963827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Clear cell renal cell carcinoma | 18791270 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Gastric cancer | 16891809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120962200-120962600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:120962200-120987200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:120962400-120963200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:120962600-120963400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:120962800-120963200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:120966000-120975600 | Weak transcription | Dnd41 | blood |